ETHZilla, trading as 180 Life Sciences Corp., has secured a $156 million convertible notes offering to bolster its Ethereum holdings. This significant investment will strengthen the company’s financial standing and enhance its strategy focused on Ethereum. The funding will be used to expand the company’s Ethereum treasury strategy. ETHZilla is committed to providing transparency updates regarding its Ethereum holdings, reflecting a strategic shift towards this cryptocurrency. 180 Life Sciences Corp., under Executive Chairman McAndrew Rudisill, announced the investment, indicating the commitment to bolstering ETH acquisitions. The increased presence of ETH in the company’s treasury will likely impact market dynamics and potentially influence other corporate investment strategies. This move may also inspire investors to reconsider their positions in cryptocurrency markets, especially Ethereum, as more corporations are investing in digital assets.